DIGITAL
The Biotech Act can help Europe compete again in life sciences but on its own cannot deliver the change that Europe urgently requires
- Nathalie MollEurope has enormous strengths in science, manufacturing and its industrial base, but struggles to translate this into investment, clinical trials
ENERGY
After Hormuz – Why preparedness and trust are the only foundations that matter
- Nelson LageNo emergency waits for us to be ready. The energy security of the future will depend on two assets built
HEALTH
Rare diseases as a strategic driver of Europe’s biotech leadership
- Avril DalyFor decades, Europe has been losing ground in the global competition for life sciences investment, research, and development. The Biotech
INDUSTRY
Europe’s preparedness will only be as strong as its vaccine and biotech base
- Juan Carlos JaramilloEurope cannot afford to rediscover preparedness only when the next crisis arrives. COVID-19 exposed deep vulnerabilities in health security, manufacturing
ENVIRONMENT
EU pharmaceutical policy at a crossroads: A call to EU Institutions and Member States to concretely act now
- Dr Alexander Natz / Stefano RomanelliThe role of the European Union (EU) in defining healthcare policy has become more prominent after the outbreak of the
